Arterial Embolization of Joint Synovitis: The Latino Registry. Midterm Follow-Up of the Latino-Hip Cohort for Greater Trochanteric Pain Syndrome CardioVascular and Interventional Radiology - To present the midterm follow-up of a cohort of 31 patients with great trochanteric pain syndrome (GTPS) refractory to conservative management or...

5/6 📌 Conclusion: LFCA embolization is a potentially viable midterm solution for hip pain reduction when conservative treatment and surgery aren't suitable.

🔗 Read more here: doi.org/doi:10.1007...

#HipPainManagement #VascularIntervention #MedTwitter #PainRelief #IR

3/6 Key Findings:

✅ Cumulative event rate significantly lower in PTAS group (11.6% vs. 34.9%, P=0.034)
✅ Median follow-up of 43 months
✅ No significant difference in ischemic strokes within 30 days or years 1-3, or secondary outcomes

#VascularIntervention

Large-bore aspiration thrombectomy for the treatment of pulmonary embolism in octogenarians - CVIR Endovascular Purpose To evaluate outcomes in patients aged ≥ 80 years following large-bore aspiration thrombectomy (LBAT) for the treatment of pulmonary embolism (PE). Materials and methods All patients ≥ 80 years of age with PE treated via LBAT at a single center were analyzed from September 2019 – August 2024. This included the octogenarian subgroup from a recently published retrospective analysis assessing all PE patients treated with LBAT at our center between September 2019 and January 2023. The following outcomes were evaluated: technical success, change in several hemodynamic measures including pulmonary artery pressure (PAP) and right ventricle to left ventricle ratio (RV to LV ratio), length of hospital and intensive-care-unit (ICU) stay, procedure-related complications, and 7- and 30-day mortality. Results Forty-eight patients aged ≥ 80 years underwent LBAT procedures for PE. Technical success was achieved in 46 cases (95.8%). The mean reduction in mean PAP was 3.6 mmHg. The mean reductio

5/6 📌 Conclusion: In this study, LBAT demonstrated high technical success (95.8%) and favorable safety outcomes in octogenarians with PE, with low major complications and a 30-day mortality rate of 6.3%.

Full study: doi.org/doi:10.1186...

#VascularIntervention

Six-Month Outcomes from the Prospective, Multi-Center, Non-Randomized Clinical Study of the COVERA(™) Arterio VeNous (AV) Stent Graft in the Treatment of Stenosis in the VEnous OutfloW of AV Fistula Access Circuits (AVeNEW PAS) CardioVascular and Interventional Radiology - The AVeNEW Post-Approval Study (AVeNEW PAS) follows upon results from the AVeNEW IDE clinical trial and was designed to provide additional clinical...

4/5 📌 Conclusion: These results supports Covera™ Stent’s safety & efficacy in managing AVF stenoses in real-world settings.

For in-depth insights, read the full study: doi.org/doi:10.1007...

#ClinicalResearch #VascularIntervention #Nephrology

3/6 Results Highlights:

✔️ 100% hemostasis success rate
✔️ No access-related complications observed
✔️ Mean manual compression time: 3.6 ± 1.2 min
✔️ Mean hemostasis time: 6.8 ± 1.4 min
✔️ 12.5% 30-day mortality rate

#PatientOutcomes #VascularIntervention

4/6 Additional Findings:

🔶 Chocolate balloons reduced flow-limiting dissection (p = 0.02)
🔶 Lower need for below-the-knee (BTK) stent implantation in chocolate balloon group (p = 0.03)
🔶 No significant improvement in AFS or major amputation reduction

#VascularIntervention #PAD

5/6 📌 Conclusion: The study reveals a significant shift in PAD treatment towards endovascular techniques, especially in OBLs.

Is this the future of PAD management?

Explore the study: doi.org/doi:10.1016...

#VascularIntervention #MedicalInnovation

5/6 📌 Conclusion: Laser atherectomy-thrombectomy offers a potentially viable primary treatment option for ALI with promising outcomes.

Explore the full study for in-depth data: doi.org/doi:10.1016...

#VascularIntervention #MinimallyInvasive #MedTwitter

4/5 📌 Conclusion: Multivariate analysis emphasizes that anatomical staging, mobility status, and CKD could significantly impact wound development in Rutherford category IV PAD patients post-endovascular therapy

Full study here: doi.org/doi:10.1186...

#VascularIntervention

2/5 Study Overview:

🔹 25 patients, age 61±10 years, 44% female
🔹 PVS technical success in all cases!
🔹 Serum albumin, Child-Pugh scores, and ALBI scores evaluated before & after PVS.

#LiverSurgery #VascularIntervention

Tumor Suppressor miR-34a: Potential Biomarker of TACE Response in HCC CardioVascular and Interventional Radiology - TACE induces variable systemic effects by producing factors that promote inflammation, oncogenesis, and angiogenesis. Here we compare concentrations of...

5/6 📌 Conclusion: While particle type didn't affect biomarker levels post-TACE, miR-34a could emerge as a predictive tool for clinical outcomes in HCC treatments.

🔗 Dive into the full study here: doi.org/doi:10.1007...

#ClinicalResearch #MedTwitter #VascularIntervention

4/5 📌 Conclusion: The IVUS-guided reentry and TD technique potentially enhance success in challenging peripheral CTO cases, providing a viable solution when bidirectional approaches aren't feasible.

Read full case details here: doi.org/doi:10.1186...

#VascularIntervention

4/5 📌 Conclusion: PEDD shows promise in optimizing selective delivery of therapeutic agents into liver tumors, potentially enhancing treatment outcomes.

Dive into the full study here: doi.org/doi:10.1016...

#TargetedTherapy #VascularIntervention @TriSalusLifeSci